Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures

Influenza virus infections remain a major and recurrent public health burden. The intrinsic ever-evolving nature of this virus, the suboptimal efficacy of current influenza inactivated vaccines, as well as the emergence of resistance against a limited antiviral arsenal, highlight the critical need f...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Pizzorno, Andrés, Terrier, Olivier, Nicolas de Lamballerie, Claire, Julien, Thomas, Padey, Blandine, Traversier, Aurélien, Roche, Magali, Hamelin, Marie-Eve, Rhéaume, Chantal, Croze, Séverine, Escuret, Vanessa, Poissy, Julien, Lina, Bruno, Legras-Lachuer, Catherine, Textoris, Julien, Boivin, Guy, Rosa-Calatrava, Manuel
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2019
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6361841/
https://ncbi.nlm.nih.gov/pubmed/30761132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00060
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi